VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: lwd who wrote (5094)	6/10/1998 2:01:00 PM
From: Vector1	Read Replies (2) of 9719

<< Does the following press release from GENZL change your view of the stock or company? Does this type of internal financing improve the scenario?>> Yes. It confirms Genzyme's commitment to the business. The company is not going to run out of money and is not going to be forced to issue a death spiral preferred. GENZ was able to do this with money borrowed at 5 1/4 % convertable at over a 50% premium to the current stock price so its a good deal for them as well. The key will be the continuation of sequential growth quarter to quarter in revs. If they can't keep the 30% pace i would sell. If they can its worth holding on. The Diacrin JV is a lottery ticket. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next